| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/20/2008 | EP1100922B1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | EP1039873B1 Keratin-based hydrogel for biomedical applications and method of production |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0986309B1 Uses of oil bodies |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0855906B1 Insoluble drug delivery |
| 02/20/2008 | EP0837687B1 Hapten modified tumor cell extract and methods of treating cancer |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128585A Recombinant production of serum albumin |
| 02/20/2008 | CN101128548A Antimicrobial cementitious composition |
| 02/20/2008 | CN101128482A Highly potent full and partial agonists and antagonists of the nociceptin receptor |
| 02/20/2008 | CN101128214A Extended GLP-1 compounds |
| 02/20/2008 | CN101128213A Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 02/20/2008 | CN101128212A Drugs for nerve cell regeneration |
| 02/20/2008 | CN101128208A Formulations and treatments for trichology |
| 02/20/2008 | CN101128207A Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 02/20/2008 | CN101126095A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126094A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101125926A Terminal amido group start-type poly (lactic-co-glycolic acid)/polyglycol block copolymer, preparation method, medicament-carried nano micelle and application |
| 02/20/2008 | CN101125891A TAT-PEIII fusion protein used for tumor partial interventional therapy and preparation method thereof |
| 02/20/2008 | CN101125883A Recombination VPC1 receptor specific agonist RVPAC1-A and its expression method and application |
| 02/20/2008 | CN101125882A Recombination PAC1 receptor agonist RMMAX and its expression method and application |
| 02/20/2008 | CN101125881A Recombination PAC1 receptor antagonist D(25-44)RMMAX and its expression method and application |
| 02/20/2008 | CN101125207A Exendin or its analogs with polyethylene group and its preparation and application |
| 02/20/2008 | CN101125206A Diolpolymer-interleukin-1 receptor antagonists conjugate and preparation method and application |
| 02/20/2008 | CN101125205A Polyethylene decorative nevin fibrinolytic enzyme and its preparation method |
| 02/20/2008 | CN101125201A Medicine composition for treating osteoporosis or preventing bone fracture caused by osteoporosis and its application |
| 02/20/2008 | CN101125200A Application of interleukin 2 and its derivative in preparing medicine for treating bronchitis |
| 02/20/2008 | CN101125199A Application of interleukin 2 and its derivative in preparing medicine for treating rhinitis |
| 02/20/2008 | CN101125198A Application of HSP27 in aspect for improving post-ischemic cardiac systolic function |
| 02/20/2008 | CN101125132A Oral insulin enteric capsule and its preparation method |
| 02/20/2008 | CN100369629C Compound hemostatic |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332596 Antifungal proteins and methods for their use |
| 02/19/2008 | US7332594 Isolated polypeptide insecticide; transformed host cell; transgenic plant |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332577 Active antithrombin content ranging from 0.03 to 0.10 mg/g of albumin, and a prekallikrein (PKA) activity that remains below 35 IU/ml over time; to increase blood volume in cardiovascular surgery |
| 02/19/2008 | US7332575 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/19/2008 | US7332574 Cell signaling associated polypeptides for identifying modulators of immune cell interactions and mamalian cellular response; tissue engineering |
| 02/19/2008 | US7332573 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptide; tumor diagnosis |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332569 Brain natriuretic peptide spliced variant |
| 02/19/2008 | US7332568 Q3 SPARC deletion mutant and uses thereof |
| 02/19/2008 | US7332567 Fret protease assays for clostridial toxins |
| 02/19/2008 | US7332526 Side effect reduction; latanoprost; it is believed that TFF-peptides may be present during healing and other related processes in the eye |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332477 Visible light and ultraviolet (UV) light sensitive composition for DNA transfer comprising an acid sensitive gene transfer agent, a photoacid generator, and a bioactive agent |
| 02/19/2008 | US7332475 administering a nasal aerosol comprising at least one member selected from reduced and oxidized glutathiones and pharmaceutically acceptable salts thereof and catechin; Coronavirus family or Flavivirus family |
| 02/19/2008 | US7332474 Peptides and related compounds having thrombopoietic activity |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332472 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 02/19/2008 | US7332471 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/19/2008 | US7332470 Methods and compositions for treating ocular disease |
| 02/19/2008 | US7332469 Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions |
| 02/19/2008 | US7332356 Fluorescent dye binding peptides |
| 02/19/2008 | US7332332 Mixture comprising sodium and potassium ions for use in transfer of exogenous nucleotide sequences into cells; genetic engineering and heterologous gene expression |
| 02/19/2008 | US7332316 Plant cytokinin oxidase |
| 02/19/2008 | US7332303 Product quality enhancement in mammalian cell culture processes for protein production |
| 02/19/2008 | US7332302 Polynucleotides encoding leukocyte adhesion inhibitor-1 (LAI-1) |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332293 Neutral amino acid transporter binding method |
| 02/19/2008 | US7332291 identification of the natural ligand for the orphan G-Protein Coupled Receptor; diagnosis of conditions involving dysregulated receptor activity |
| 02/19/2008 | US7332287 Methods and compositions for diagnosing breast cancer |
| 02/19/2008 | US7332276 Administering steroid compound |
| 02/19/2008 | US7332173 Group A streptococcal polysaccharide immunogenic compositions and methods |
| 02/19/2008 | US7332166 Glycosylated specificity exchangers |
| 02/19/2008 | US7332164 Heterobifunctional polymeric bioconjugates |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | US7332160 Medical device and method for tissue removal and repair |
| 02/19/2008 | US7332159 Method and composition for inhibiting reperfusion injury in the brain |
| 02/19/2008 | US7332156 Methods of treating wounds using IL-23 |
| 02/19/2008 | US7331920 Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same |
| 02/19/2008 | CA2383977C Stably preserving oxygen infusion |
| 02/19/2008 | CA2310400C Novel physiologically active substance sulphostin, process for producing the same, and use thereof |
| 02/19/2008 | CA2301889C Water-soluble dry compositions |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2263795C Chemically modified polypeptides |
| 02/19/2008 | CA2253287C A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 02/19/2008 | CA2220505C N,o-carboxymethylchitosan for prevention of surgical adhesions |
| 02/19/2008 | CA2216856C Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
| 02/19/2008 | CA2209858C Il-2r-associated polypeptide and dna molecules coding therefor |
| 02/19/2008 | CA2206670C Heat treated blood plasma proteins |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2162260C Methods and formulations for use in treating oophorectomized women |
| 02/19/2008 | CA1341567C Dna sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides |
| 02/14/2008 | WO2008019395A2 Compounds for improving learning and memory |
| 02/14/2008 | WO2008019394A2 Methods for treatment and diagnosis of psychiatric disorders |
| 02/14/2008 | WO2008019378A1 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 02/14/2008 | WO2008019371A1 Combination therapy |
| 02/14/2008 | WO2008019368A2 Albumin-insulin fusion proteins |
| 02/14/2008 | WO2008019346A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/14/2008 | WO2008019322A2 Methods of inhibiting and reducing tumor growth using human mannose-binding lectin |
| 02/14/2008 | WO2008019303A2 Pyridazinonyl macrocyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | WO2008019289A2 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | WO2008019266A2 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors |